Home Singulair Lawsuits

Singulair Lawsuits

Singulair lawsuits claim adults and children who took the asthma drug Singulair (montelukast) suffered severe mental health side effects. The FDA added its most severe warning for serious behavior and mood-related changes in 2020. Plaintiffs claim Merck failed to adequately warn patients, parents and doctors of the risk.

This is an active lawsuit
See if you can file

See If You Qualify for a Singulair Lawsuit

If you or a loved one was diagnosed with a mental health disorder after taking Singulair, you may be entitled to compensation.

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one of Drugwatch's trusted legal partners. This is legal advertising.
Last Modified: August 19, 2021
Fact Checked
Fact-Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Why Are Singulair Lawsuits Being Filed?

Singulair, also known as montelukast, is prescribed for severe allergies and asthma in adults and children. But in March 2020, the U.S. Food and Drug Administration added a boxed warning — the agency’s strongest label warning — for serious mental health side effects.

Now plaintiffs, including the parents of children who suffered psychiatric disorders after taking Singulair, are filing lawsuits that accuse Merck of: Designing a defective drug, negligence and failure to warn about the risk of mental problems.

Families File Lawsuits

Lawsuits say Merck knew or should have known before it started selling Singulair in 1998 that the drug could cause neuropsychiatric injuries during treatment and even after stopping.

For example, Stephanie Hammar filed a lawsuit on behalf of her minor son, R.S.B., in the Eastern District of Wisconsin in September 2020. R.S.B. took Singulair from December 2010 to August 2012 and the drug caused him to be admitted to an inpatient psychiatric center, according to the lawsuit.

Hammar’s son was admitted for homicidal and suicidal thoughts. Doctors diagnosed him with major depressive disorder, anxiety disorder, obsessive-compulsive disorder, sexual thoughts, poor coping and other mental problems.

Black Box Warning Led to Lawsuits

Plaintiffs began filing lawsuits shortly after the FDA added a black box warning for serious neuropsychiatric events to Singulair’s drug label in March 2020.

A black box warning is the FDA’s most severe warning. These warnings contain important side effect information surrounded by a thick black border and bold lettering to warn of permanent, serious or fatal side effects.

Singulair Black Box Timeline
  • March 4, 2020
    The FDA announced it was adding a black box warning for serious mental health side effects because many health care professionals, patients and caregivers were not aware of the risk.
  • Aug. 28, 2009
    The FDA announced an update to Singulair’s Precautions section of the prescribing information for neuropsychiatric events including, “postmarket cases of agitation, aggression, anxiousness, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal thinking and behavior (including suicide), and tremor.”
  • March 3, 2008
    The FDA announced it was investigating “a possible association between the use of Singulair and behavior/mood changes, suicidality (suicidal thinking and behavior) and suicide.”
Were you or a loved one diagnosed with a mental health disorder after taking Singulair?

Do I Qualify for a Singulair Lawsuit?

If you or a loved one took brand name Singulair and received a diagnosis of a mental health disorder, you may qualify to file a Singulair lawsuit for compensation.

Neuropsychiatric disorders linked to Singulair include:
  • Major depressive disorder
  • Suicide
  • Institutionalization for psychiatric disorders
  • Obsessive-compulsive disorder
  • Homicidal thoughts
  • Suicidal thoughts
  • Non-psychiatric injury
  • Anxiety disorder
  • Other psychiatric disorders

In general, the time limit to file a claim for injuries caused by a drug is about three years, but this varies by state and may be less.

This can change depending on when you took the drug or when you discovered the drug’s side effects. Make sure you contact an attorney right away if you believe you qualify to file a claim.

Filing on Behalf of a Family Member

Parents or caregivers can file on behalf of their children, and family members can file a suit for loved ones who died as a result of Singulair side effects.

When parents file on behalf of their child, they claim damages they incurred as guardians of the child, such as paying for medical bills. They also file for injuries their child suffered. Wrongful death claims are filed on behalf of deceased family members.

Experienced law firms can walk parents and family members through the process of starting a claim.

Preparing to File a Lawsuit

Once you’ve confirmed you took brand name Singulair and have received a diagnosis, it’s time to start the lawsuit process.

Step 1: Finding an Experienced Law Firm

The first thing you need to do is find a law firm that has experience handling complex pharmaceutical litigation claims.

It’s an important decision, so make sure you ask about the firm’s track record and experience. Remember, you can interview more than one firm.

Step 2: Preparing Necessary Documentation

Once you’ve decided on the law firm you want to hire, sign up for a free consultation.

Before you talk to your attorney, make sure you have proof you took brand name Singulair, such as a receipt. Also gather medical records showing your diagnosis.

If you have difficulty getting these records, your attorney may be able to help.

Step 3: File the Claim

Once your attorney has determined you qualify to file a claim, he or she will start the process by writing up the complaint and filing the claim in the appropriate court.

Is There a Singulair Class-Action Lawsuit?

So far, there are no class action lawsuits for Singulair’s mental health side effects. The lawsuits currently being filed are individual lawsuits.

Members of class actions don’t get to choose their attorneys, and all the members of the class are awarded the same amount of money regardless of the severity of their injuries. For this reason, most drug lawsuits similar to Singulair lawsuits are individual claims.

When hundreds or thousands of plaintiffs sue the same defendants for similar injuries, a judge may decide to consolidate the cases into multidistrict litigation (MDL).

Cases in an MDL may share some resources such as discovery and experts, but each individual chooses their own lawyer and any settlement or jury verdict amount is based on the individual merits of their case.

Please seek the advice of a medical professional before making health care decisions.
Related Pages